SBC Medical Group Holdings Incorporated - Common Stock (SBC)

SBC Medical Group (NASDAQ:SBC) held its 2026 annual meeting of stockholders in a virtual format, with Chairman and Chief Executive Officer Yoshiyuki Aikawa presiding over the meeting. Aikawa said the virtual format was intended to be “more inclusive” and allow the company to reach a greater number

SBC Medical Group (NASDAQ:SBC) reported first-quarter 2026 revenue of $43 million, down 9% from a year earlier, as management said prior fee structure revisions continued to weigh on reported results even as underlying clinic activity improved. Yuya Yoshida, chief financial officer of SBC Medical G

SBC Medical Group's Q3 2025 earnings show a mixed picture: revenue declined 18%, but net income surged 353%, sending the stock higher.

SBC Medical Group's Q2 2025 results missed estimates with revenue down 18% and EPS at $0.02. Franchise growth and customer loyalty offer long-term hope despite short-term challenges.

SBC Medical (NASDAQ: SBC) Announces New Translation App After Zacks & Sidoti Initiate Coverage, Emphasize Strong Growth

SBC Medical Showcases Growth Strategy By Announcing New Acquisition While Also Unveiling New B2B Offering

Potential Opportunities In Cosmetic Healthcare Highlighted Through SBC Medical’s Story

SBC Medical Group (Nasdaq: SBC) CEO: "If We Become No. 1 In Asia, I Believe We Will Become No. 1 In The World"

Research published in the journal Addiction indicates that GLP-1 drugs like Ozempic may play a crucial role in reducing substance abuse.

SBC Medical Group (Nasdaq: SBC) Earnings Update: H1 2024 Revenue Up 29% And Net Income Up 123%